Neuronavigation Systems Comprehensive Study by Type (Optical System (ENT, Maxillofacial, Spinal, and Neurosurgery), Electromagnetic System (Cranial and ENT Surgical Procedures)), Application (Neurosurgery, ENT Surgery, Maxillofacial Surgery, Spinal Surgery), End User (Hospitals, Ambulatory Surgical Centers, Others) Players and Region - Global Market Outlook to 2026

Neuronavigation Systems Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 15.35%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Growing incidence and high prevalence of several neurological disorders related to brain and spine, tumors, and other neurovascular disorders are projected to lead the growth of the neuronavigation systems market globally. Neuronavigation systems help neurosurgeons during serious operations that are executed within the confines of the brain as well as the spinal column. It helps in guiding the surgery precisely by providing an exact outline of the surrounding neurovascular structures. Additionally, it provides intra-operative orientation to the specialists that help them in formulating a precise surgical method toward the targeted lesion. Rapidly rising medical tourism industry in the area, government initiatives indorsing health care infrastructure in many nations, and increase in health care expenditure. These factors are act as a key driver of neuronavigation systems market. Also, Escalating adoption of optical technologies including fluoroscopy and computed tomography (CT) based technologies will help to boost market all over the world.
According to AMA, the market for Neuronavigation Systems is expected to register a CAGR of 15.35% during the forecast period to 2026. This growth is primarily driven by Increasing Need and Rising Demand for Accurate and Precise Systems, Growing Adoption of Minimally Invasive Surgical Procedures and Rising Regulatory Approval for Navigation Systems.

Globally, a noticeable market trend is evident Developments in Augmented Reality (AR) Navigation Systems . The Medical Devices sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Stryker (United States), Medtronic plc (Ireland), Brainlab AG (Germany), Scopis GmbH (Germany), ClaroNav (Canada), Surgical Theater, LLC (United States), Synaptive Medical (Canada), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany) and General Electric Company (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 12th March 2019, Smith & Nephew has agreed to acquire the Brainlab orthopedic joint reconstruction business. This deal will help Smith & Nephew’s strategy to invest in best in class technologies that further its multi-asset digital surgery as well as the robotic ecosystem. The acquisition and strategic collaboration allow both companies to accelerate research and development in the areas of digital surgery and augmented reality.

Regulatory Insights:
US requires all importing companies to appoint a registered United States Food and Drug Administration (USFDA) agent to act as a connection between the company and the USFDA. “When marketing a device which is a predicate device to USFDA, the manufacturers are required to prove substantial equivalence by submitting a 510(k) application, a Premarket Approval application (PMA). Understanding the requirements and checking for exemptions of premarket notification [510(k)] will save time and resources for manufacturer before deciding upon submission.”

Market Drivers
  • Increasing Need and Rising Demand for Accurate and Precise Systems
  • Growing Adoption of Minimally Invasive Surgical Procedures
  • Rising Regulatory Approval for Navigation Systems

Market Trend
  • Developments in Augmented Reality (AR) Navigation Systems
  • Upsurging Preference for Optical Navigation Technology among Surgeons
  • Fueling Demand Due To Increase in Orthopedic, Neurological and ENT Disorders

Restraints
  • High Cost of Neuronavigation Systems

Opportunities
Increasing Adoption of Surgical Navigation Systems in Ambulatory Settings and Untapped APAC market and Huge Demand Due to Technological Advancements and Aging Population
Challenges
Side Effects Associated With Open Brain Surgeries

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Neuronavigation Systems Study Sheds Light on
— The Neuronavigation Systems Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Neuronavigation Systems industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Neuronavigation Systems industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Optical System [ENT, Maxillofacial, Spinal, and Neurosurgery]
  • Electromagnetic System [Cranial and ENT Surgical Procedures]
By Application
  • Neurosurgery
  • ENT Surgery
  • Maxillofacial Surgery
  • Spinal Surgery
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Need and Rising Demand for Accurate and Precise Systems
      • 3.2.2. Growing Adoption of Minimally Invasive Surgical Procedures
      • 3.2.3. Rising Regulatory Approval for Navigation Systems
    • 3.3. Market Challenges
      • 3.3.1. Side Effects Associated With Open Brain Surgeries
    • 3.4. Market Trends
      • 3.4.1. Developments in Augmented Reality (AR) Navigation Systems
      • 3.4.2. Upsurging Preference for Optical Navigation Technology among Surgeons
      • 3.4.3. Fueling Demand Due To Increase in Orthopedic, Neurological and ENT Disorders
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Neuronavigation Systems, by Type, Application, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Neuronavigation Systems (Volume)
      • 5.2.1. Global Neuronavigation Systems by: Type (Volume)
        • 5.2.1.1. Optical System [ENT, Maxillofacial, Spinal, and Neurosurgery]
        • 5.2.1.2. Electromagnetic System [Cranial and ENT Surgical Procedures]
      • 5.2.2. Global Neuronavigation Systems by: Application (Volume)
        • 5.2.2.1. Neurosurgery
        • 5.2.2.2. ENT Surgery
        • 5.2.2.3. Maxillofacial Surgery
        • 5.2.2.4. Spinal Surgery
      • 5.2.3. Global Neuronavigation Systems by: End User (Volume)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Centers
        • 5.2.3.3. Others
      • 5.2.4. Global Neuronavigation Systems Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Neuronavigation Systems (Price)
      • 5.3.1. Global Neuronavigation Systems by: Type (Price)
  • 6. Neuronavigation Systems: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Stryker (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Medtronic plc (Ireland)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Brainlab AG (Germany)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. Scopis GmbH (Germany)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. ClaroNav (Canada)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Surgical Theater, LLC (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Synaptive Medical (Canada)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. Koninklijke Philips N.V. (Netherlands)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Siemens AG (Germany)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. General Electric Company (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
  • 7. Global Neuronavigation Systems Sale, by Type, Application, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Neuronavigation Systems (Volume)
      • 7.2.1. Global Neuronavigation Systems by: Type (Volume)
        • 7.2.1.1. Optical System [ENT, Maxillofacial, Spinal, and Neurosurgery]
        • 7.2.1.2. Electromagnetic System [Cranial and ENT Surgical Procedures]
      • 7.2.2. Global Neuronavigation Systems by: Application (Volume)
        • 7.2.2.1. Neurosurgery
        • 7.2.2.2. ENT Surgery
        • 7.2.2.3. Maxillofacial Surgery
        • 7.2.2.4. Spinal Surgery
      • 7.2.3. Global Neuronavigation Systems by: End User (Volume)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Centers
        • 7.2.3.3. Others
      • 7.2.4. Global Neuronavigation Systems Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Neuronavigation Systems (Price)
      • 7.3.1. Global Neuronavigation Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Neuronavigation Systems Sales: by Type(K Units)
  • Table 2. Neuronavigation Systems Sales Optical System [ENT, Maxillofacial, Spinal, and Neurosurgery] , by Region K Units (2015-2020)
  • Table 3. Neuronavigation Systems Sales Electromagnetic System [Cranial and ENT Surgical Procedures] , by Region K Units (2015-2020)
  • Table 4. Neuronavigation Systems Sales: by Application(K Units)
  • Table 5. Neuronavigation Systems Sales Neurosurgery , by Region K Units (2015-2020)
  • Table 6. Neuronavigation Systems Sales ENT Surgery , by Region K Units (2015-2020)
  • Table 7. Neuronavigation Systems Sales Maxillofacial Surgery , by Region K Units (2015-2020)
  • Table 8. Neuronavigation Systems Sales Spinal Surgery , by Region K Units (2015-2020)
  • Table 9. Neuronavigation Systems Sales: by End User(K Units)
  • Table 10. Neuronavigation Systems Sales Hospitals , by Region K Units (2015-2020)
  • Table 11. Neuronavigation Systems Sales Ambulatory Surgical Centers , by Region K Units (2015-2020)
  • Table 12. Neuronavigation Systems Sales Others , by Region K Units (2015-2020)
  • Table 13. South America Neuronavigation Systems Sales, by Country K Units (2015-2020)
  • Table 14. South America Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 15. South America Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 16. South America Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 17. Brazil Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 18. Brazil Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 19. Brazil Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 20. Argentina Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 21. Argentina Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 22. Argentina Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 23. Rest of South America Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 24. Rest of South America Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 25. Rest of South America Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 26. Asia Pacific Neuronavigation Systems Sales, by Country K Units (2015-2020)
  • Table 27. Asia Pacific Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 28. Asia Pacific Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 29. Asia Pacific Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 30. China Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 31. China Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 32. China Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 33. Japan Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 34. Japan Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 35. Japan Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 36. India Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 37. India Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 38. India Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 39. South Korea Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 40. South Korea Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 41. South Korea Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 42. Taiwan Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 43. Taiwan Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 44. Taiwan Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 45. Australia Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 46. Australia Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 47. Australia Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 48. Rest of Asia-Pacific Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 49. Rest of Asia-Pacific Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 50. Rest of Asia-Pacific Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 51. Europe Neuronavigation Systems Sales, by Country K Units (2015-2020)
  • Table 52. Europe Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 53. Europe Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 54. Europe Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 55. Germany Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 56. Germany Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 57. Germany Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 58. France Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 59. France Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 60. France Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 61. Italy Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 62. Italy Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 63. Italy Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 64. United Kingdom Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 65. United Kingdom Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 66. United Kingdom Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 67. Netherlands Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 68. Netherlands Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 69. Netherlands Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 70. Rest of Europe Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 71. Rest of Europe Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 72. Rest of Europe Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 73. MEA Neuronavigation Systems Sales, by Country K Units (2015-2020)
  • Table 74. MEA Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 75. MEA Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 76. MEA Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 77. Middle East Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 78. Middle East Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 79. Middle East Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 80. Africa Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 81. Africa Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 82. Africa Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 83. North America Neuronavigation Systems Sales, by Country K Units (2015-2020)
  • Table 84. North America Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 85. North America Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 86. North America Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 87. United States Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 88. United States Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 89. United States Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 90. Canada Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 91. Canada Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 92. Canada Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 93. Mexico Neuronavigation Systems Sales, by Type K Units (2015-2020)
  • Table 94. Mexico Neuronavigation Systems Sales, by Application K Units (2015-2020)
  • Table 95. Mexico Neuronavigation Systems Sales, by End User K Units (2015-2020)
  • Table 96. Neuronavigation Systems: by Type(USD/Units)
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Neuronavigation Systems Sales: by Type(K Units)
  • Table 108. Neuronavigation Systems Sales Optical System [ENT, Maxillofacial, Spinal, and Neurosurgery] , by Region K Units (2021-2026)
  • Table 109. Neuronavigation Systems Sales Electromagnetic System [Cranial and ENT Surgical Procedures] , by Region K Units (2021-2026)
  • Table 110. Neuronavigation Systems Sales: by Application(K Units)
  • Table 111. Neuronavigation Systems Sales Neurosurgery , by Region K Units (2021-2026)
  • Table 112. Neuronavigation Systems Sales ENT Surgery , by Region K Units (2021-2026)
  • Table 113. Neuronavigation Systems Sales Maxillofacial Surgery , by Region K Units (2021-2026)
  • Table 114. Neuronavigation Systems Sales Spinal Surgery , by Region K Units (2021-2026)
  • Table 115. Neuronavigation Systems Sales: by End User(K Units)
  • Table 116. Neuronavigation Systems Sales Hospitals , by Region K Units (2021-2026)
  • Table 117. Neuronavigation Systems Sales Ambulatory Surgical Centers , by Region K Units (2021-2026)
  • Table 118. Neuronavigation Systems Sales Others , by Region K Units (2021-2026)
  • Table 119. South America Neuronavigation Systems Sales, by Country K Units (2021-2026)
  • Table 120. South America Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 121. South America Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 122. South America Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 123. Brazil Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 124. Brazil Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 125. Brazil Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 126. Argentina Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 127. Argentina Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 128. Argentina Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 129. Rest of South America Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 130. Rest of South America Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 131. Rest of South America Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 132. Asia Pacific Neuronavigation Systems Sales, by Country K Units (2021-2026)
  • Table 133. Asia Pacific Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 134. Asia Pacific Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 135. Asia Pacific Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 136. China Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 137. China Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 138. China Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 139. Japan Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 140. Japan Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 141. Japan Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 142. India Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 143. India Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 144. India Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 145. South Korea Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 146. South Korea Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 147. South Korea Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 148. Taiwan Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 149. Taiwan Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 150. Taiwan Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 151. Australia Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 152. Australia Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 153. Australia Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 154. Rest of Asia-Pacific Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 155. Rest of Asia-Pacific Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 156. Rest of Asia-Pacific Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 157. Europe Neuronavigation Systems Sales, by Country K Units (2021-2026)
  • Table 158. Europe Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 159. Europe Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 160. Europe Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 161. Germany Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 162. Germany Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 163. Germany Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 164. France Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 165. France Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 166. France Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 167. Italy Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 168. Italy Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 169. Italy Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 170. United Kingdom Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 171. United Kingdom Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 172. United Kingdom Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 173. Netherlands Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 174. Netherlands Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 175. Netherlands Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 176. Rest of Europe Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 177. Rest of Europe Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 178. Rest of Europe Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 179. MEA Neuronavigation Systems Sales, by Country K Units (2021-2026)
  • Table 180. MEA Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 181. MEA Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 182. MEA Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 183. Middle East Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 184. Middle East Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 185. Middle East Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 186. Africa Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 187. Africa Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 188. Africa Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 189. North America Neuronavigation Systems Sales, by Country K Units (2021-2026)
  • Table 190. North America Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 191. North America Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 192. North America Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 193. United States Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 194. United States Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 195. United States Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 196. Canada Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 197. Canada Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 198. Canada Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 199. Mexico Neuronavigation Systems Sales, by Type K Units (2021-2026)
  • Table 200. Mexico Neuronavigation Systems Sales, by Application K Units (2021-2026)
  • Table 201. Mexico Neuronavigation Systems Sales, by End User K Units (2021-2026)
  • Table 202. Neuronavigation Systems: by Type(USD/Units)
  • Table 203. Research Programs/Design for This Report
  • Table 204. Key Data Information from Secondary Sources
  • Table 205. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Neuronavigation Systems: by Type K Units (2015-2020)
  • Figure 5. Global Neuronavigation Systems: by Application K Units (2015-2020)
  • Figure 6. Global Neuronavigation Systems: by End User K Units (2015-2020)
  • Figure 7. South America Neuronavigation Systems Share (%), by Country
  • Figure 8. Asia Pacific Neuronavigation Systems Share (%), by Country
  • Figure 9. Europe Neuronavigation Systems Share (%), by Country
  • Figure 10. MEA Neuronavigation Systems Share (%), by Country
  • Figure 11. North America Neuronavigation Systems Share (%), by Country
  • Figure 12. Global Neuronavigation Systems: by Type USD/Units (2015-2020)
  • Figure 13. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 14. Stryker (United States) Revenue: by Geography 2020
  • Figure 15. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 16. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 17. Brainlab AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Brainlab AG (Germany) Revenue: by Geography 2020
  • Figure 19. Scopis GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Scopis GmbH (Germany) Revenue: by Geography 2020
  • Figure 21. ClaroNav (Canada) Revenue, Net Income and Gross profit
  • Figure 22. ClaroNav (Canada) Revenue: by Geography 2020
  • Figure 23. Surgical Theater, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 24. Surgical Theater, LLC (United States) Revenue: by Geography 2020
  • Figure 25. Synaptive Medical (Canada) Revenue, Net Income and Gross profit
  • Figure 26. Synaptive Medical (Canada) Revenue: by Geography 2020
  • Figure 27. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 28. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2020
  • Figure 29. Siemens AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens AG (Germany) Revenue: by Geography 2020
  • Figure 31. General Electric Company (United States) Revenue, Net Income and Gross profit
  • Figure 32. General Electric Company (United States) Revenue: by Geography 2020
  • Figure 33. Global Neuronavigation Systems: by Type K Units (2021-2026)
  • Figure 34. Global Neuronavigation Systems: by Application K Units (2021-2026)
  • Figure 35. Global Neuronavigation Systems: by End User K Units (2021-2026)
  • Figure 36. South America Neuronavigation Systems Share (%), by Country
  • Figure 37. Asia Pacific Neuronavigation Systems Share (%), by Country
  • Figure 38. Europe Neuronavigation Systems Share (%), by Country
  • Figure 39. MEA Neuronavigation Systems Share (%), by Country
  • Figure 40. North America Neuronavigation Systems Share (%), by Country
  • Figure 41. Global Neuronavigation Systems: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Stryker (United States)
  • Medtronic plc (Ireland)
  • Brainlab AG (Germany)
  • Scopis GmbH (Germany)
  • ClaroNav (Canada)
  • Surgical Theater, LLC (United States)
  • Synaptive Medical (Canada)
  • Koninklijke Philips N.V. (Netherlands)
  • Siemens AG (Germany)
  • General Electric Company (United States)
Additional players considered in the study are as follows:
Orthalign, Inc. (United States) , Heal Force Bio-Meditech Holdings Limited (Hong Kong) , Parsiss Co. (Iran) , B. Braun Melsungen AG (United States) , Zimmer Biomet Holdings, Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2021 204 Pages 93 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Neuronavigation Systems market is expected to see a CAGR of 15.35% during projected year 2020 to 2026.
Top performing companies in the Global Neuronavigation Systems market are Stryker (United States), Medtronic plc (Ireland), Brainlab AG (Germany), Scopis GmbH (Germany), ClaroNav (Canada), Surgical Theater, LLC (United States), Synaptive Medical (Canada), Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany) and General Electric Company (United States), to name a few.
North America is dominating the Neuronavigation Systems Market.

Know More About Global Neuronavigation Systems Market Report?